Activest Wealth Management
NKTR icon

Activest Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

Activest Wealth Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.1K Hold
200
– – ﹤0.01% 545
2026
Q2 		$14K Hold
200
– – ﹤0.01% 514
2026
Q1 		$14.4K Hold
200
– – ﹤0.01% 603
2025
Q4 		$8.46K Hold
200
– – ﹤0.01% 691
2025
Q3 		$11.4K Hold
200
– – ﹤0.01% 478
2025
Q2 		$5.17K Hold
200
– – ﹤0.01% 544
2025
Q1 		$2.04K Hold
200
– – ﹤0.01% 656
2024
Q4 		$2.79K Hold
200
– – ﹤0.01% 412
2024
Q3 		$3.9K Hold
200
– – ﹤0.01% 384
2024
Q2 		$3.72K Buy
+200
New +$4.22K ﹤0.01% 364

Other funds holding NKTR

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return
LVW Advisors
LVW Advisors Pittsford, New York $1.19B AUM 19.73% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Activest Wealth Management's NKTR Position: Q3 2026 in Review

Activest Wealth Management held its Nektar Therapeutics (NKTR) position steady in Q3 2026 at 200 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Activest Wealth Management first reported a position in NKTR in Q2 2024 and has held it in 10 quarters since. The position peaked at $14.4K in Q1 2026. 32 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Activest Wealth Management held 200 shares of Nektar Therapeutics worth $12.1K as of Q3 2026.
  • Activest Wealth Management left its Nektar Therapeutics share count unchanged in Q3 2026.
  • Nektar Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #545 holding.
  • Activest Wealth Management first reported a position in Nektar Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • Activest Wealth Management's Nektar Therapeutics position peaked at $14.4K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.